Calumet (CLMT) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

$2.79

Estimate

$1.80

Surprise

+55.1%

Revenue (period 2026-09-30)

$1.68B

Score today

6.3/10

Revenue source: xbrl.

Calumet (CLMT) beat the $1.80 estimate with adjusted EPS of $2.79 — a large 55.1% upside surprise.

• Calumet Q3 2026 Earnings Call Transcript — benzinga, 2026-11-06
• Calumet, Inc. Reports Third Quarter 2026 Financial Results — fiscal.ai, 2026-11-06
• Calumet Specialty Prods Q3 EPS $2.91 Beats $1.59 Estimate, Sales $1.682B Beat $1.344B Estimate — benzinga, 2026-11-06

TrendMatrix currently rates CLMT Sell at 6.3/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +55.1% surprise compares with a +118.4% four-quarter average.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$39.64

Price target

$48.55

Stop

$37.89

Upside to target

+22.5%

Reward-to-risk

1.5:1

Model outputs from TrendMatrix’s engine as of 2026-11-07 — shown for context, not personalized investment advice.

Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.

Industry

Specialty Chemicals

Market cap

$3.48B

P/E (fwd)

12.4

52-week range

$17.85–$59.87

Off 52-week high

33.8%

RSI (14)

20

Volume vs avg

1.93×

Score today

6.3/10